ArticleSpringerPlus2015

A phase I dose-escalation study of a biosimilar trastuzumab in Chinese metastasis breast cancer patients.

Xinna Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.